Chagas disease screening in pregnant Latin American women: Adherence to a systematic screening protocol in a non-endemic country.
Central America
/ epidemiology
Chagas Disease
/ diagnosis
Cross-Sectional Studies
Female
Guideline Adherence
/ statistics & numerical data
Humans
Infectious Disease Transmission, Vertical
/ statistics & numerical data
Mass Screening
/ methods
Pregnancy
Pregnancy Complications, Parasitic
/ epidemiology
Retrospective Studies
Seroepidemiologic Studies
South America
/ epidemiology
Trypanosoma cruzi
/ isolation & purification
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
02
11
2020
accepted:
01
03
2021
revised:
05
04
2021
pubmed:
25
3
2021
medline:
30
6
2021
entrez:
24
3
2021
Statut:
epublish
Résumé
Chagas disease (CD) is a chronic parasitic disease caused by Trypanosoma cruzi and is endemic to continental Latin America. In Spain, the main transmission route is congenital. We aimed to assess adherence to regional recommendations of universal screening for CD during pregnancy in Latin American women in the province of Alicante from 2014 to 2018. Retrospective quality study using two data sources: 1) delivery records of Latin American women that gave birth in the 10 public hospitals of Alicante between January 2014 and December 2018; and 2) records of Chagas serologies carried out in those centers between May 2013 and December 2018. There were 3026 deliveries in Latin American women during the study period; 1178 (38.9%) underwent CD serology. Screening adherence ranged from 17.2% to 59.3% in the different health departments and was higher in Bolivian women (48.3%). Twenty-six deliveries (2.2%) had a positive screening; CD was confirmed in 23 (2%) deliveries of 21 women. Bolivians had the highest seroprevalence (21/112; 18.7%), followed by Colombians (1/333; 0.3%) and Ecuadorians (1/348; 0.3%). Of 21 CD-positive women (19 Bolivians, 1 Colombian, 1 Ecuadorian), infection was already known in 12 (57.1%), and 9 (42.9%) had already been treated. Only 1 of the 12 untreated women (8.3%) was treated postpartum. Follow-up started in 20 of the 23 (87.0%) neonates but was completed only in 11 (47.8%); no cases of congenital transmission were detected. Among the 1848 unscreened deliveries, we estimate 43 undiagnosed cases of CD and 1 to 2 undetected cases of congenital transmission. Adherence to recommendations of systematic screening for CD in Latin American pregnant women in Alicante can be improved. Strategies to strengthen treatment of postpartum women and monitoring of exposed newborns are needed. Currently, there may be undetected cases of congenital transmission in our province.
Sections du résumé
BACKGROUND
Chagas disease (CD) is a chronic parasitic disease caused by Trypanosoma cruzi and is endemic to continental Latin America. In Spain, the main transmission route is congenital. We aimed to assess adherence to regional recommendations of universal screening for CD during pregnancy in Latin American women in the province of Alicante from 2014 to 2018.
METHODOLOGY/PRINCIPAL FINDINGS
Retrospective quality study using two data sources: 1) delivery records of Latin American women that gave birth in the 10 public hospitals of Alicante between January 2014 and December 2018; and 2) records of Chagas serologies carried out in those centers between May 2013 and December 2018. There were 3026 deliveries in Latin American women during the study period; 1178 (38.9%) underwent CD serology. Screening adherence ranged from 17.2% to 59.3% in the different health departments and was higher in Bolivian women (48.3%). Twenty-six deliveries (2.2%) had a positive screening; CD was confirmed in 23 (2%) deliveries of 21 women. Bolivians had the highest seroprevalence (21/112; 18.7%), followed by Colombians (1/333; 0.3%) and Ecuadorians (1/348; 0.3%). Of 21 CD-positive women (19 Bolivians, 1 Colombian, 1 Ecuadorian), infection was already known in 12 (57.1%), and 9 (42.9%) had already been treated. Only 1 of the 12 untreated women (8.3%) was treated postpartum. Follow-up started in 20 of the 23 (87.0%) neonates but was completed only in 11 (47.8%); no cases of congenital transmission were detected. Among the 1848 unscreened deliveries, we estimate 43 undiagnosed cases of CD and 1 to 2 undetected cases of congenital transmission.
CONCLUSIONS/SIGNIFICANCE
Adherence to recommendations of systematic screening for CD in Latin American pregnant women in Alicante can be improved. Strategies to strengthen treatment of postpartum women and monitoring of exposed newborns are needed. Currently, there may be undetected cases of congenital transmission in our province.
Identifiants
pubmed: 33760816
doi: 10.1371/journal.pntd.0009281
pii: PNTD-D-20-01929
pmc: PMC8021187
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0009281Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS Negl Trop Dis. 2019 May 31;13(5):e0007271
pubmed: 31150377
J Travel Med. 2021 Jan 6;28(1):
pubmed: 32946555
PLoS Negl Trop Dis. 2019 Oct 24;13(10):e0007694
pubmed: 31647811
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Clin Infect Dis. 2013 Feb;56(4):496-502
pubmed: 23097582
Adv Parasitol. 2011;75:19-47
pubmed: 21820550
PLoS Negl Trop Dis. 2015 Feb 13;9(2):e0003540
pubmed: 25680190
Epidemiol Infect. 2014 Apr;142(4):888-90
pubmed: 23916094
Acta Trop. 2010 Jul-Aug;115(1-2):14-21
pubmed: 19932071
Acta Trop. 2015 Aug;148:77-88
pubmed: 25917718
Enferm Infecc Microbiol Clin. 2008 Dec;26(10):609-13
pubmed: 19100190
Trop Med Int Health. 2018 Jun;23(6):634-640
pubmed: 29683542
Enferm Infecc Microbiol Clin. 2012 Aug;30(7):380-2
pubmed: 22277372
Enferm Infecc Microbiol Clin. 2010 May;28(5):284-93
pubmed: 19962790
Acta Trop. 2008 Jun;106(3):195-9
pubmed: 18448076
Lancet. 2018 Jan 6;391(10115):82-94
pubmed: 28673423
Enferm Infecc Microbiol Clin. 2013 Apr;31(4):210-6
pubmed: 22621813
Euro Surveill. 2011 Sep 22;16(38):
pubmed: 21958531
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3312
pubmed: 25411847
PLoS Negl Trop Dis. 2015 Sep 25;9(9):e0004103
pubmed: 26406325
An Pediatr (Barc). 2018 Mar;88(3):122-126
pubmed: 28411096
N Engl J Med. 2014 May 15;370(20):1899-908
pubmed: 24827034
Arch Dis Child. 2015 Jan;100(1):90-4
pubmed: 25210104
Enferm Infecc Microbiol Clin. 2013 Oct;31(8):535-42
pubmed: 23374862
Arch Dis Child. 2010 Mar;95(3):224-8
pubmed: 19948512
Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43
pubmed: 25671846
Am J Trop Med Hyg. 2020 Jul;103(1):437-444
pubmed: 32342845
Acta Trop. 2011 May;118(2):110-7
pubmed: 21396345
BMC Public Health. 2014 Nov 21;14:1201
pubmed: 25416081
Biomed Res Int. 2014;2014:401864
pubmed: 24949443
Am J Trop Med Hyg. 2010 Nov;83(5):1044-7
pubmed: 21036835
Trop Med Int Health. 2016 May;21(5):590-6
pubmed: 26932338
Trop Med Int Health. 2020 Jul;25(7):752-763
pubmed: 32279399
Lancet Infect Dis. 2018 Apr;18(4):419-430
pubmed: 29352704
Euro Surveill. 2020 Feb;25(8):
pubmed: 32127121
Am J Trop Med Hyg. 2012 Nov;87(5):832-6
pubmed: 22987653
Rev Clin Esp. 2012 Jul;212(7):366-8
pubmed: 22497857
Epidemiol Infect. 2012 Oct;140(10):1896-903
pubmed: 22129521
Euro Surveill. 2011 Sep 22;16(38):
pubmed: 21958533
Glob Health Action. 2016 Mar 11;9:30201
pubmed: 26976265
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:17-30
pubmed: 19753454
Trop Med Int Health. 2000 Apr;5(4):293-301
pubmed: 10810029
BJOG. 2014 Jan;121(1):22-33
pubmed: 23924273
Euro Surveill. 2019 Jun;24(26):
pubmed: 31266591